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Androgen sensitivity and prostate-specific antigen (PSA) production are hallmarks of the prostatic phenotype, both benign and malignant, which are of clinical importance. Thus, androgen-sensitive, PSA-producing cancer models are desirable for study; however, most cell lines are considered inadequate models because they lack the characteristics of androgen sensitivity and PSA production. At present, only the PSA-positive prostate cancer cell line, LNCaP, is available. 2 Currently, androgen deprivation therapy is the most effective treatment for advanced prostate cancer. However, the deprivation therapy eventually fails, because the metastatic prostate cancer within an individual patient is composed heterogeneously of clones of both androgen-dependent and -independent cancer cells. Therefore, androgen-independent cancer cell lines, for example, PC-3, are utilized as an androgen-independent cancer model.
As an alternative treatment, suicide gene therapy in prostate cancer has been reported, in which a gene can be introduced locally using an adenoviral vector into cancer cells, making them sensitive to a drug that is normally nontoxic. [3] [4] [5] The suicide genes used often encode enzymes that metabolize nontoxic prodrugs into toxic metabolites. One of the most frequently used suicide genes is the herpes simplex virus thymidine kinase (HSV-tk) gene, 6 which phosphorylates a prodrug, ganciclovir (GCV), into a toxic form. A powerful characteristic of HSV-tk/GCV therapy is that the transduction of a small fraction of the tumor cells with the suicide gene can result in widespread tumor cell death (bystander effect). The cell to cell transfer of HSV-tk-activated GCV between HSV-tk-transduced tumor cells and neighboring unmodified cells via gap junctions is a major mechanism of the bystander effect. 7 Gap junctions are composed of connexin subunits and connect the cytoplasmic domains of contacting cells, allowing ionic and metabolic exchange between them. However, many cancer cell lines are deficient in gap junctions. 8 Such a deficiency, which is also found in human prostate tumors, 9 can limit the extent of the bystander effect in suicide gene therapy. However, the bystander effect has been reported to be enhanced by introducing a connexin gene with the HSV-tk gene in vitro. 7 The development of nonviral and tumor-selective delivery vectors for in vivo gene transfer is necessary for the clinical application of therapeutic genes. Synthetic vectors such as lipid nanoparticles (liposome and emulsion) have become an attractive choice due to their lack of immunogenicity, the potential for tissue-specific targeting, relative safety and a relatively easy large-scale production. For targeted delivery to tumors, the folate receptor (FR) has been used since FR has been identified as a marker for ovarian carcinomas 10 and has also been found to be frequently overexpressed in a wide range of other types of tumors. 11 Folic acid retains its receptor-binding and endocytotic properties when covalently linked to a wide variety of molecules. Liposomes conjugated to a folate ligand via a polyethyleneglycol (PEG)-spacer have been used for the delivery of chemotherapeutic agents and plasmid DNA to receptor-bearing tumor cells, for example, human oral cancer KB cells. [12] [13] [14] [15] However, the use of a folate ligand as a targeting ligand to deliver DNA has not been successful in in vivo gene therapy. 13, 14 Folatelinked liposomes administered intraperitoneally showed just the transfection activity of a reporter gene (luciferase gene) in a disseminated intraperitoneal tumor model. 13 An FR-targeted lipoplex caused no increase in accumulation when systemically administered. 14 In human prostate tissue, high-affinity folate binding protein has also been characterized. 16 However, the type of folate binding protein expressed in human prostate has not been reported. Therefore, the use of a folate ligand as a targeting ligand to deliver DNA is a potential strategy for the treatment of prostate cancer.
Previously, we reported that a folate-linked cationic nanoparticle could deliver DNA with high transfection efficiency into KB cells via FR and into LNCaP cells where the expression of FRs was not observed, 17 but did not provide enough transfection efficiency in an in vivo experiment. In this study, we developed new folate-linked nanoparticle (NP-F) to enhance the gene expression in LNCaP, PC-3 and KB cells, and evaluated the transfection with NP-F from the cytotoxic effects in the cells and xenografts with HSV-tk and connexin 43 (Cx43) genes. The therapeutic effect of the HSV-tk genes was observed in both KB and LNCaP tumor xenografts.
Materials and methods

Plasmid constructions
pCMV-tk was constructed using a cDNA fragment (589 bp) coding for a cytomegalovirus (CMV) promoter amplified by PCR with a pEGFP-C1 plasmid (Clontech, CA) containing a green fluorescent protein (GFP) reporter gene under the control of the CMV promoter as a template, and the following CMV promoter-specific primers: CMV promoter forward primer (5 0 ATGG TACCTAGTTATTAATAGTAATCAA) and CMV promoter reverse primer (5 0 TCAAGCTTGATCTGACGG TTCACTAAAC). The forward and reverse primers, respectively, contained KpnI and HindIII restriction sites. The cDNA coding for bp 1-1131 of HSV-tk was amplified by PCR using the pLXSN plasmid containing the HSV-tk gene with a midkine promoter 18 as a template with the following HSV-tk-specific primers: HSV-tk forward primer (5 0 ATCAATGGaccATGGCTTCGTA CCCC) and HSV-tk reverse primer (5 0 CATCTAGATCA GTTAGCCTCCCCCAT). The forward primer contained a 3 bp optimal Kozak sequence (in lowercase letters) together with an NcoI restriction site (underlined). The reverse primer coded for bp 1114-1131 of HSV-tk with an XbaI restriction site (underlined). After the HSV-tk cDNA amplification, this cDNA was digested with NcoI and XbaI and ligated into an NcoI/XbaI-digested pGL3-enhancer (Promega, Madison, WI). The plasmid was then digested with KpnI and HindIII, and ligated with the CMV promoter cDNA.
In the construction of pSV40-Cx43, total RNA was isolated from KB cells using NusleoSpin RNA II (Macherey-Nagel, Germany). First-strand cDNA was synthesized from 5 mg of total RNA after denaturation for 5 minutes at 651C using 50 pmol of random primer, 0.5 mM dNTP and 5 U of AMV reverse transcriptase XL (Takara Shuzo Co., LTD, Japan). The reaction was performed at 411C for 1 hour in a 20 ml volume. The cDNA coding bp 1-1149 of human Cx43 was amplified by PCR using the synthesized cDNA from KB cells as a template and the following Cx43-specific primers: Cx43 forward primer (5 0 ATCAATGGaccATGGGTGACTG GAGCGCCT) and Cx43 reverse primer (5 0 CATCTAGA CTAGATCTCCAGGTCATCAG.). The forward primer contained a 3-bp optimal Kozak sequence (in lowercase letters) together with an NcoI restriction site (underlined). The reverse primer coded for bp 1129-1149 of Cx43 with an XbaI restriction site (underlined). After the Cx43 cDNA amplification, this cDNA was digested with NcoI and XbaI and was ligated into an NcoI/XbaI-digested pGL3-control (Promega, Madison, WI) with the simian virus (SV40) promoter.
A protein-free preparation of the plasmid was purified following alkaline lysis using maxiprep columns (Qiagen, Hilden, Germany).
Preparation of FITC-labeled oligonucleotide DNA
The FITC-labeled 30-mer randomized oligonucleotide and its compliment (FITC-ODN) were synthesized with a phosphodiester backbone (Sigma Genosys Japan, Hokkaido, Japan). The two oligonucleotides were mixed and annealed to make double-stranded DNA.
Preparation, size and z-potential of nanoparticles and nanoplexes
Folate-polyethyleneglycol-distearoylphoshatidylethanolamine (f-PEG-DSPE) (mean molecular weight of PEG: 2 kDa) was synthesized. 17 3([N-(N 0 ,N 0 -dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) was purchased from Sigma Chemical Co. (St Louis, MO). Tween 80 (99% purity) was obtained from NOF Co. Ltd (Tokyo, Japan). Nanoparticles were prepared by a modified ethanol injection method as previously described. 17 For example, in the case of NP-2F (NP-F), DC-Chol:Tween 80:f-PEG-DSPE at 93:5:2 molar ratio (10:1.3:1.3, weight) was dissolved in about 5 ml of ethanol, and then the ethanol was removed with a rotary evaporator till 1-2 ml was left. Next, a constant volume of water was added to the ethanol solution. The nanoparticles formed instantly after further evaporation of the residual ethanol. The concentration of DC-Chol was adjusted to 1 mg/ml in the final nanoparticle suspension with water. Then, the nanoparticle suspension was filtered through 0.45-mm Millex-HA filters (Millipore, Cork, Ireland) to sterilize it. Based on a preliminary experiment, the optimized ratio of cationic lipid to DNA was determined as 3:1. The nanoplex at a charge ratio ( þ /À) of 3/1 and Tfx20 (Promega, Madison, WI) lipoplex at a charge ratio ( þ /À) of 2/1 of cationic lipid to DNA were formed by addition of each nanoparticle (9.5 ml) or Tfx20 (6 ml) to 2 mg of DNA with gentle shaking and leaving at room temperature for 10 minutes. The particle size distributions and the z-potentials were measured by the dynamic light scattering method and the electrophoresis light scattering method, respectively (ELS-800, Otsuka Electronics Co., Ltd, Osaka, Japan), at 251C after the dispersion was diluted to an appropriate volume with water. The stability of nanoparticles and nanoplexes was assessed by measuring changes in size after 30 days and dilutions in 10 or 50% serum, respectively.
In vitro experiments
Cell culture. LNCaP cells were supplied by the Department of Urology, Keio University Hospital (Tokyo, Japan). PC-3 and KB cells were from the Cell Resource Center for Biomedical Research, Tohoku University (Miyagi, Japan). A human cervix carcinoma cell line, HeLa 229, was supplied by the Department of Virology, Toyama Medical and Pharmaceutical University (Toyama, Japan). A human hepatoblastoma cell line, HepG2, was obtained from the Riken Cell Bank (Ibaraki, Japan). All the cell lines used in this study were grown in a folatedeficient RPMI 1640 medium (Life Technologies Inc., Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies Inc.) and kanamycin (100 mg/ml) at 371C in a 5% CO 2 humidified atmosphere.
Luciferase gene transfection in the cells and luciferase assay
The pCMV-luc encoding the luciferase gene was supplied by Dr Tanaka at the Mt Sinai School of Medicine (NY, USA). Cell cultures were prepared by plating cells in a 35-mm culture dish 24 hours prior to each experiment. The nanoplex at a charge ratio ( þ /À) of 3/1 and Tfx20 lipoplex at a charge ratio ( þ /À) of 2/1 of cationic lipid to DNA were formed by addition of each nanoparticle (9.5 ml) or Tfx20 (6 ml) to 2 mg of DNA with gentle shaking and leaving at room temperature for 10 minutes. Each nanoplex was diluted in 1 ml of complete medium and then incubated for 24 hours. Luciferase expression was measured according to the luciferase assay system (Pica gene luciferase assay kit, Toyo Ink Mfg Co. Ltd, Tokyo, Japan) as previously reported. 17 RT-PCR analysis of FR expression in the cells. Total RNA was isolated from LNCaP, PC-3, KB, HeLa and HepG2 cells, using NusleoSpin RNA II as described in the section above. Total RNA from tumor human prostate tissue was obtained from Ambion Inc. (Austin, TX). RNA yield and purity were checked by spectrometric measurement at 260 and 280 nm and RNA electrophoresis, respectively. For RT-PCR, a 25-ml reaction volume contained 1 ml of synthesized cDNA, 10 pmol of each specific primer pair and 0.25 U of Ex Taq DNA polymerase (Takara Shuzo Co., LTD) with a PCR buffer containing 1.5 mM MgCl 2 and 0.2 mM of each dNTP. The profile of PCR amplification consisted of denaturation at 941C for 0.5 minutes, primer annealing at 581C for 0.5 minutes and elongation at 721C for 1 minute for 25 cycles. PCRs of the housekeeping gene b-actin, FRs (FR-a, -b, -g) and reduced folate carrier (RFC) were performed at the same cycle run for all samples. The PCR products for FRs, RFC and b-actin were analyzed by 1.5% agarose gel electrophoresis in a Tris-Borate-EDTA (TBE) buffer. The products were visualized by ethidium bromide staining.
Flow cytometric analysis. KB and LNCaP cell cultures were prepared by plating cells in a 35-mm culture dish 24 hours prior to each experiment. In competition assay, 9.5 ml of DiI-labeled NP-F was mixed with 2 mg of FITC-ODN and then diluted in 1 ml of folate-deficient RPMI medium containing 10% serum. KB cells were incubated with the nanoplex in the presence or absence of 1 mM folic acid for 3 hours. In cellular association based on FITC-ODN, 9.5 ml of NP-F was mixed with 2 mg of FITC-ODN and then diluted in 1 ml of the medium. LNCaP and PC-3 cells, respectively, were incubated with the nanoplex for 3 or 24 hours. After incubation, the dishes were washed two times with 1 ml of PBS (pH 7.4) to remove any unbound nanoplex, and the cells were detached with 0.25% trypsin. The cells were centrifuged at 1500 g, and the supernatant was discarded and resuspended with PBS containing 0.1% bovine serum albumin (BSA) and 1 mM EDTA. The suspended cells were directly introduced into a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA) equipped with a 488-nm argon ion laser. Data for 10,000 fluorescent events were obtained by recording forward scatter (FSC), side scatter (SSC) and green (530/30 nm) and red (585/42 nm) fluorescences.
Confocal microscopy. LNCaP and PC-3 cells were plated into 35-mm culture dishes. DiI-labeled NP-F (9.5 ml) was mixed with 2 mg of FITC-ODN and pEGFP plasmid coding enhanced GFP under the control of the CMV promoter (Clontech, CA), and then diluted in 1 ml of medium supplemented with 10% serum. The cells were incubated with the mixture for 24 hours. Examinations were performed with a Radiance 2100 confocal laser scanning microscope (BioRad, CA), as previously described. 17 For DiI, maximal excitation was performed with the 543-nm line of an internal He-neon laser, and fluorescence emission was observed with a long-pass barrier filter 560DCLP. FITC-ODN and GFP were imaged using the 488-nm excitation line of an argon laser, and fluorescence emission was observed with a filter, HQ515/30.
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Association of an FITC-labeled folate-BSA conjugate. Synthesis of an FITC-labeled folate-BSA conjugate (FITC-f-BSA) was carried out. 19 Briefly, folic acid was dissolved in anhydrous dimethylsulfoxide and activated with a five-fold excess of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide for 1 hour at room temperature. The activated folate was then reacted with FITC-labeled BSA (Sigma Chemical Co.) in phosphate buffer (pH 7.4). Excess folate was removed from conjugated protein using a PD-10 desalting column (Amersham Bioscience Corp., Piscataway, NJ).
PC-3 cells were prepared by plating cells in a 35-mm culture dish 24 hours prior to each experiment. FITC-f-BSA was diluted to 30 mM in 1 ml of folate-deficient RPMI medium containing 10% serum and then incubated with cells in the presence or absence of 1 mM folic acid. After 3 hours incubation, the dishes were washed two times with 1 ml of PBS (pH 7.4) to remove the unbound FITC-f-BSA. FITC-f-BSA was visualized with confocal laser scanning microscopy, as described in the section above.
Immunohistochemistry. Unstained formalin-fixed, paraffin-embedded normal and cancerous prostate tissue slides (Chemicon Select Tissue array: TMA3202, Chemicon International, Temecula, CA) were deparaffinized and rinsed in Tris-buffered saline with 1% Tween 20 (TBST, pH 7.4). Sections were incubated for 1 hour with 1% skim milk in TBST, then rinsed in TBST and again incubated at room temperature with mouse anti-human FR-a monoclonal IgG (Mov18/ZEL, Alexis Biochemicals, San Diego, CA) diluted 1:500 with 1% skim milk in TBST. Next, tissue sections were exposed to FITC-labeled goat anti-mouse IgG Ab (KPL, Guildford, UK) for 1 hour at room temperature. After a wash with TBST, the antigen-antibody complex was visualized with confocal laser scanning microscopy, as described in the section above.
Analysis of GCV metabolites using anion-exchange HPLC. The accumulation of GCV mono-, di-and triphosphate (GCV-MP, GCV-DP and GCV-TP, respectively), in LNCaP and PC-3 cells, was determined using pCMV-tk-transfected cells seeded in a 35-mm culture dish after 24 hours incubation with 100 mg/ml GCV as previously reported. 20 The separation of GCV and its phosphorylated metabolites was performed using a Waters 616 LC HPLC system with UV detection (Milford, MA). The separation of metabolites was accomplished using a Senshu Pak SAX-1253P column (250 Â 4.6 mm, Senshu Scientific Co., LTD, Tokyo, Japan).
Sensitivity to the GCV assay. LNCaP and PC-3 cells were seeded at a density of 1 Â 10 4 cells per well in 96-well plates and maintained for 12 hours before transfection in folate-deficient RPMI medium supplemented with 10% serum. The cells were transfected with the NP-F nanoplexes of the 0.2 mg pGL3-enhancer as a control DNA, 0.1 mg pCMV-tk plus 0.1 mg pGL3-enhancer (Promega), 0.1 mg pGL3-enhancer plus 0.1 mg pSV40-Cx43 and 0.1 mg pCMV-tk plus 0.1 mg pSV40-Cx43. After 12 hours incubation, the culture medium was replaced with medium containing various concentrations of GCV ranging from 0.1 to 1000 mg/ml. The number of surviving cells was determined by a WST-8 assay (Dojindo Laboratories, Kumamoto, Japan) after 4 days exposure to GCV.
In vivo experiments
Xenograft tumor model. Male BALB/c nu/nu mice (8 weeks of age, CLEA Japan Inc., Tokyo, Japan) were maintained on a folate-deficient rodent diet (Oriental Yeast Co., LTD, Tokyo, Japan) on arrival and for the duration of the study. To generate KB tumor xenografts, 1 Â 10 7 cells suspended in 50 ml of RPMI medium were inoculated subcutaneously in the flank region of the mice. To generate LNCaP tumor xenografts, 1 Â 10 7 LNCaP cells suspended in 50 ml of RPMI medium containing 60% reconstituted basement membrane (Matrigel: Collaborative Research, Bedford, MA) were inoculated subcutaneously into the flank region of the mice. In LNCaP tumor xenografts, to maintain the serum testosterone level, the male mice were i.p. administered 0.5 mg of testosterone propionate (Wako Pure Chemical Industries, Ltd, Osaka, Japan) dissolved in olive oil once every other day. The tumor volume was calculated using the formula tumor volume ¼ 0. , 5 mg of pCMV-luc was transfected by direct injection into xenografts with NP-F (24 ml) and Tfx20 (15 ml). After 24 hours, the tumors were excised and immediately homogenized after adding lysis buffer (Promega, Madison, WI) in a volume (ml) equivalent to five times the tissue weight (mg). The tissue homogenate was centrifuged at 20,000 g for 5 minutes after undergoing one round of freeze-thawing. The resulting supernatants were assayed with a luminometer and the luciferase activity was determined in the same manner as in vitro.
Assessment of KB or LNCaP tumor growth. When the average volume of KB xenograft tumors reached 150 mm 3 (day 0), these mice were divided into two groups: group I, pGL3-enhancer (10 mg) as a control; group II, pCMV-tk (10 mg). Both experimental groups consisted of six tumors. The NP-F nanoplexes of 10 mg of plasmid per tumor were directly injected into xenografts on days 0, 2, 4 and 6. GCV at a dose of 25 mg/kg was administered i.p. at 24 and 36 hours after the injections of nanoplexes. The tumor volume was measured at days 0, 2, 4, 6, 8, 11 and 13. At day 14, all mice were killed, and the tumor weights and serum concentration of folic acid were measured. The serum concentration of folic acid was determined by a competitive enzyme immunoassay (AIA-Pack folate, Tosoh Co., Tokyo, Japan) on a Tosoh AIA system
When the volume of LNCaP xenograft tumors reached 60 mm 3 on average (day 0), these mice were divided into two groups as follows; group I, pGL3-enhancer (10 mg) as a control; and group II, pCMV-tk (5 mg) plus pSV40-Cx43 (5 mg). Each experimental group consisted of six tumors. The NP-F nanoplexes of 10 mg plasmid DNA were transfected by direct injection into xenografts with NP-F (50 ml) on days 0, 3, 5 and 7. GCV at a dose of 25 mg/kg was administered i.p. at 24 and 36 hours after the injection of the nanoplex. The tumor volume was measured on days 0, 3, 5, 7, 9 and 11. The data are shown as the mean7SE. The animal experiments were conducted with ethical approval from our institutional animal care and use committee.
Statistical analysis
The statistical significance of the data was evaluated with Student's t-test. A P-value of 0.05 or less was considered significant.
Results
Size and z-potential of nanoparticles and nanoplexes
We prepared and characterized folate-targeted nanoparticles with four different formulations. All nanoparticle formulations consisted of 1 mg/ml DC-Chol as a cationic lipid, and 5 mol% Tween 80 (NP). In this study, we changed from low-purity to high-purity Tween 80 to improve the transfection efficiency. For FR-targeted vectors, NP-1F, -2F and -3F contained 1, 2 and 3 mol% f-PEG-DSPE, respectively. The average size of each nanoparticle was about 100-200 nm ( Table 1 ). The zpotential of NP, NP-1F and -2F was about 53, 44 and 39 mV, respectively, decreasing as the amount of f-PEG-DSPE added increased, except for NP-3F. The physical characteristics of the nanoplex were also investigated at the optimal charge ratio ( þ /À) of (3/1) of cationic nanoparticle to DNA. When the nanoparticles were mixed with DNA, the size of each nanoplex increased from 200 to 500 nm, and the z-potential slightly decreased from þ 40 to B þ 30 mV. In the presence of 10 and 50% serum, the sizes of the NP, NP-1F and -3F nanoplexes increased up to 500-660 nm, whereas that of NP-2F was 430 nm.
Luciferase expression in cell lines
To optimize the formula of folate-linked nanoparticles, we evaluated the transfection efficiency of NP, NP-1F, NP-2F and NP-3F by measuring luciferase activity in KB, LNCaP and PC-3 cells transfected using pCMV-luc in the presence of 10% serum for 24 hours. Nanoparticles linked to 2 mol% folic acid, NP-2F, showed the highest level of luciferase activity of all the nanoparticles in any cell lines (Fig 1a-c) . The optimal folic acid content of nanoparticles was 2 mol%. In subsequent experiments, therefore, we used NP-2F, referred to as NP-F.
To compare the effectiveness of transfection of NP-F with Tfx20, a commercial gene transfection reagent, we measured the luciferase activity in five kinds of cell lines. Compared with Tfx20, NP-F showed five-fold higher transfection efficiency in PC-3 cells, but about 20-fold lower transfection in LNCaP cells (Fig 2a) . However, NP-F showed higher transfection efficiencies in LNCaP, PC-3 and HeLa cells than in HepG2 and KB cells.
Expression of FR mRNA in the cell lines
To examine the mechanism of cellular uptake of folatelinked nanoparticles, we investigated the expression of FRs and RFC in the cell lines using the RT-PCR method. There were three FR isoforms, a, b and g with distinctive patterns of tissue distribution. FR-a mRNA was expressed strongly in KB and HeLa cells, but not expressed in LNCaP, PC-3 or HepG2 cells (Fig 2b) . FR-b and -g mRNAs were not expressed in any of the cell lines (data not shown). RFC, a carrier-mediated folate transporter, was weakly expressed in all cell lines evaluated (Fig 2b) . This suggested that the cellular uptake of folate-linked nanoparticles in HeLa and KB cells was mediated via FR-a, following the induction of transfection activity. In HepG2 cells, FR mRNA was not expressed, following the induction of about 100-fold less transfection activity, compared with Tfx20. In LNCaP and PC-3 cells, FR mRNAs were not observed; however, NP-F induced 
and 3 mol% f-PEG-DSPE (NP, NP-1F, NP-2F andNP-3F, respectively). Each value represents the mean7SD (n ¼ 3).
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Association of NP-F nanoplex with KB cells
We examined the selectivity of NP-F to carry genes into KB cells using a nonexchangeable fluorescent membrane probe, DiI-labeled NP-F complexed with FITC-ODN, by flow cytometry. As shown in Figure 3a and b, all the cells took up a similar amount of both the fluorescent NP-F and DNA. A comparative experiment in the presence of 1 mM folic acid revealed decreased amount of NP-F and DNA in the cells. These results clearly indicated that the association of NP-F nanoplex with KB cells occurred via FR.
Association of FITC-f-BSA with PC-3 cells and immunohistochemistry
To examine the selectivity of the folate moiety in cellular uptake into PC-3 cells, FITC-f-BSA was visualized by Suicide gene therapy by folate-linked nanoparticle Y Hattori and Y Maitani confocal microscopy. As shown in Figure 4a and b, FICT-f-BSA was associated with the cells. A comparative experiment in the presence of 1 mM folic acid showed a significant decrease in the amount of FICT-f-BSA associated with the cells (Fig 4c and d) . These results indicated that the folate moiety accelerated the cellular association of FITC-f-BSA with PC-3 cells.
For an assessment of FR expression in human malignant tumor biopsy specimens, we immunohistochemically stained paraffin-embedded sections for FR-a. In tumor samples, FR-a protein expression was evident in three of four biopsy specimens evaluated (Fig 4e and f) . There was positive FR-a staining around the epithelium of the cancerous duct. FR-a mRNA was detected in the RNA from tumor prostate tissue by RT-PCR (data not shown). In contrast, no staining was observed when normal sections were incubated with the FR-a antibody (data not shown).
Transfection efficiency and localization of nanoplexes visualized by confocal microscopy and flow cytometry
To clarify the ability of NP-F to carry genes into LNCaP and PC-3 cells, we examined the efficiency of the transfection of NP-F into LNCaP and PC-3 cells with the pEGFP-C1 plasmid. In both LNCaP (Fig 5a) and PC-3 cells (Fig 5b) , strong expression of GFP protein was observed in 2-3% of cells, and weak expression in almost all other cells by confocal microscopy, corresponding to the luciferase expression in both cells (Fig 2a) .
Next, we examined the localization of a nonexchangeable fluorescent membrane probe, DiI-labeled NP-F complexed with FITC-ODN, after transfection into LNCaP cells. The distribution pattern of the DiI red signal on NP-F was observed at the cell surface weakly at 3 hours (Fig 5c) and strongly at 24 hours after transfection (Fig 5d) . In contrast, the FITC signal was detected throughout the cytoplasm strongly at 3 hours (Fig 5c) and then diffusively at 24 hours after the transfection (Fig 5d) . Mostly, the DiI and FITC signals were not colocalized in the cytoplasm. A flow cytometric study also demonstrated that the FITC intensity in LNCaP cells was stronger at 3 hours than at 24 hours after the transfection (Fig 5e) , suggesting that the DNA was released from the nanoplex and diffused into the cytoplasm. In PC-3 cells, the signal intensity was also strong at 3 hours after the transfection (data not shown).
In vitro sensitivity of cells transfected transiently with pCMV-tk and pSV40-Cx43 to GCV
In order to confirm the transfection of pCMV-tk with NP-F, we analyzed the GCV metabolites in LNCaP and PC-3 cells. GCV-TP, the most abundant triphosphate produced, was clearly detected in the transfected cells, while there was no detectable phosphorylation of GCV in nontransfected cells (data not shown).
Next, LNCaP and PC-3 cells were transiently transfected with the NP-F nanoplex using various plasmids: pCMV-tk, pSV40-Cx43 and combinations thereof (Fig 6) . The degree of sensitivity to GCV was compared as the IC 50 . In LNCaP cells, the pCMV-tk-transfected cells showed significantly higher sensitivity to GCV than the control (85.6-fold increase), or pSV40-Cx43-transfected cells (6.6-fold increase) (Fig 6a) . The cells cotransfected with pCMV-tk and pSV40-Cx43 exhibited increased sensitivity to GCV (101.8-fold increase compared with the control). This result suggests that pCMV-tk and pSV40-Cx43 induced a cytotoxic effect by GCV in the transfected cells, and that the combination of pCMV-tk and pSV40-Cx43 may display a bystander effect.
In PC-3 cells, the pCMV-tk-transfected cells showed significant sensitivity to GCV compared with the control (Fig 6b) , but the pSV40-Cx43-transfected cells did not. The sensitivity to GCV was not enhanced in the cells transfected with pCMV-tk plus pSV40-Cx43. This result suggests that pSV40-Cx43 did not display a bystander effect in PC-3 cells.
Luciferase expression in the xenografts
To evaluate the transfection efficiency of NP-F in KB tumor xenografts, we measured luciferase activity after direct injection of NP-F nanoplex into xenografts compared with Tfx20. NP-F showed about 100 times higher transfection than Tfx20 in vivo (data not shown).
In vivo suicide gene therapy in KB or LNCaP tumor xenografts
We evaluated the antitumor effect by direct injection into KB tumor xenografts with the NP-F nanoplex of pCMVtk. When KB cells were transiently transfected with the NP-F nanoplex using various plasmids, pCMV-tk, pSV40-Cx43 and combinations thereof, the pCMV-tktransfected cells showed significant sensitivity to GCV compared with the control, but did not with the cells cotransfected with pCMV-tk and pSV40-Cx43 (data not shown). Therefore, NP-F nanoplex of pCMV-tk was used in KB tumor xenografts. The growth of KB tumors was significantly inhibited in the mice treated with the NP-F nanoplex (Fig 7a) on day 13. A comparison of tumor weight and appearance after excision also demonstrated that the tumor growth was attenuated in the mice treated with the nanoplex of pCMV-tk (Fig 7b and c) . In the mice fed a folate-deficient diet, the serum concentrations of folic acid were approximately 50 nM, which was significantly lower than the concentration in the mice fed a normal diet (200 nM) (data not shown). Next, we evaluated the antitumor effect by direct injection into LNCaP tumor xenografts with the NP-F nanoplex of pCMV-tk plus pSV40-Cx43 (Fig 8) , because this nanoplex was the most effective in the in vitro experiments with LNCaP cells (Fig 6a) . Tumor growth was suppressed in the mice treated with the NP-F nanoplex of pCMV-tk plus pSV40-Cx43, but not in the control mice. The mean survival times of the control mice and the mice treated with the nanoplex of pCMV-tk plus pSV40-Cx43 were 21.5 and 33 days, respectively (data not shown).
Discussion
One major problem in gene therapy is how to transfect target cells efficiently and specifically. Previously, we reported that the NP-1F vector, composed of 94 mol% DC-Chol, 5 mol% conventional Tween 80 (about 50% pure; Tokyo Kasei Kogyo Ltd, Tokyo, Japan) and 1 mol% f-PEG-DSPE, exhibited selective uptake in KB cells in vitro, but had less transfection efficiency than Tfx20. 17 In the present study, we changed from low-purity to high-purity Tween 80 (99% pure). NP-2F (NP-F), composed of 93 mol% DC-Chol, 5 mol% high-purity Tween 80 and 2 mol% f-PEG-DSPE, exhibited five times higher transfection efficiency than the NP-1F prepared in the previous study (0.2 Â 10 3 cps/mg protein). 17 Furthermore, NP-F formed an injectable nanoplex of about 200 nm (Table 1) , even in the presence of serum, did not aggregate and maintained its size (about 400 nm). This suggests the usefulness of NP-F as a selective and hightransfection vector in vivo for cancer cells overexpressing FR. High-purity Tween 80 may provide greater steric Figure 6 Sensitivity of LNCaP (a) and PC-3 (b) cells to GCV. The cells were transfected with various plasmids using NP-F. After 12 hours incubation, the medium was changed to one containing GCV. The plasmids used were pGL3-enhancer as a control plasmid (K), pCMV-tk (J), pSV40-Cx43 (') and pCMV-tk plus pSV40-Cx43 (&). Data points indicate the mean7SD (n ¼ 3). *Po0.05 and **Po0.01, compared with pCMV-tk and pSV40-Cx43 in (a). *Po0.05 and **Po0.01, compared with pCMV-tk in (b).
Suicide gene therapy by folate-linked nanoparticle Y Hattori and Y Maitani stabilization and stronger fusogenic activity in the particles. 21 This could be one of the reasons why high levels of transfection activity were observed in the formula difference between the previous 17 and present study. A reduction in the z-potential with the addition of f-PEG-DSPE was not observed in NP-3F (about 55 mV).
f-PEG-DSPE might not be incorporated into NP-3F particles. The concentration of folate-PEG 2000 -DSPE in NP-2F and 3F was about 40 and 60 mM, respectively. f-PEG-DSPE below the critical micelle concentration (CMC) might lead to an efficient incorporation into the particles. However, f-PEG-DSPE above the CMC may help to stabilize micellized f-PEG-DSPE and to inefficient insertion into the particle. The CMC of f-PEG-DSPE may be between 40 and 60 mM and might affect the incorporation of f-PEG-DSPE in NP-3F.
We optimized the nanoparticle formula, 2 mol%-folate-linked, NP-F, by evaluating the transfection efficiency of 1-3 mol% folate-linked nanoparticles since NP-F showed significantly high DNA transfection in KB, LNCaP and PC-3 cells (Fig 1a-c) . In prostate cancer, there have been no reports of the expression of FR in either cultured human prostate cell lines or tissue specimens, and an evaluation of the expression of FR mRNAs by RT-PCR indicated an absence of FR mRNAs in LNCaP and PC-3 cells (Fig 2b) . However, NP-F showed relatively high transfection activity in prostate cancer cells compared to KB and HeLa cell lines, which strongly expressed FR-a mRNA (Fig 2a) . This suggests the usefulness of NP-F as an effective DNA transfection reagent for the prostate androgen-dependent and -independent cancer cells. The FR-specific delivery with the NP-F nanoplex in KB cells was compared in the absence or presence of 1 mM folic acid in the medium. The association of the nanoplex with the cells was reduced in the presence of free folic acid (Fig 3a and b) . This suggests that an association via interaction between the folate moiety of NP-F and FR of KB cells is a major route of NP-F nanoplex transfection, corresponding with a previous study. 22 In the human prostate, high-affinity folate binding protein was characterized, 16 and folic acid binds to the membrane fraction that crossreacts with the anti-prostate-specific membrane antigen (PSMA) antibody. 23 PSMA is a transmembrane protein with an overexpressed pattern restricted to malignant human prostate tissue and LNCaP cells. 24 The physiological role of PSMA in prostate cancer remains unknown, but PSMA shows hydrolase enzymatic activity with a folate substrate 23 and is internalized via an endocytic mechanism. 25 If PSMA functions as a receptor mediating the internalization of a putative ligand similar to folic acid, this suggests that the folate-linked nanoparticle binds to PMSA and is then taken up via an endocytic mechanism by LNCaP cells as we reported. 17 In PC-3 cells, our study using RT-PCR confirmed the presence of RFC mRNA, but found no FR or PSMA mRNAs (data not shown). However, FITC-f-BSA was taken up by PC-3 cells and the cellular association was significantly decreased in the presence of 1 mM folic acid (Fig 4a-d) . We cannot exclude the possibility that the uptake of NP-F in PC-3 cells was mediated by RFC; however, it is not clear what kind of receptor enhances the uptake of folate-linked nanoparticles.
In prostate cancer, we observed potential discrepancies between cultured cells and tissue specimens in the expression of FR. We found that FR-a protein was expressed in cancerous tissue (Fig 4e and f) , but not in LNCaP or PC-3 cells (Fig 2b) . Immunohistochemistry indicated the expression of FR-a around the epithelium of the cancerous duct, but not in the normal prostate tissues evaluated in the present study. Therefore, NP-F will be potentially useful as a prostate tumor-specific vector via FR for in vivo gene therapy. Further studies will be required to determine the relationship between normal and malignant prostate tissue specimens in the expression of FR.
The HSV-tk/GCV therapy system relies on the expression of the exogenous HSV-tk gene in the cancer cells. HSV-tk gene expression was confirmed by the production of GCV metabolites (data not shown) and cell growth inhibition in the presence of GCV (Fig 6) . HSV-tkexpressing cells can induce the death of nonexpressing neighbors via gap junctions (bystander effect). 7, 26 In the normal human prostate, the cells communicate via gap junctions, whereas, in poorly differentiated prostate cancer, the expression of Cx43 decreased and gap junctional intracellular communication failed. 8, 9 Transfection of the Cx43 gene into Cx43-deficient LNCaP cells may enhance the bystander effect, and was reported to inhibit cell growth, retard tumorigenicity and induce differentiation. 27 In LNCaP cells, the pCMV-tk-transfected cells showed significant sensitivity to GCV compared with the control (Fig 6a) . Although the pSV40-Cx43-transfected cells did not show growth inhibition without GCV, they showed significant sensitivity similar to the pCMV-tk-transfected cells at high concentrations of GCV. Connexins assembled into hexamers insert into the plasma membrane, and dock in an opposed membrane to form gap junction channels. 28 It is generally assumed that the surface expression of an unjunctional channel, a hemichannel, is closed to prevent metabolic stress and death caused by the collapse of the ionic gradient and influx of Ca 2 þ , but it can be opened under physiological and pathological conditions. 29 In the pSV40-Cx43-transfected cells, the hemichannel might be opened by unknown factors, and induce intracellular influx of a large amount of GCV. Since with a high concentration of GCV, nonphosphated GCV showed cytotoxicity in the control cells, the cytotoxicity in pSV40-Cx43-transfected cells might be caused by the intracellular influx of GCV, even at low concentrations of GCV. The cells transfected with pCMV-tk plus pSV40-Cx43 had increased sensitivity to GCV, compared with those transfected with only pSV40-Cx43 or pCMV-tk. This may be due to an enhanced cytotoxic effect by GCV metabolites and a bystander effect on transfection.
In PC-3 cells, the pCMV-tk-transfected cells showed significant sensitivity to GCV compared with the control (Fig 6b) . In contrast, the cells transfected with pCMV-tk plus pSV40-Cx43 did not exhibit an increase in sensitivity to GCV compared with pCMV-tk-transfected cells. The expression of Cx43 in LNCaP cells may induce the formation of gap junctions, but that in PC-3 cells may not, 30 suggesting the absence of a bystander effect. The major limitation of in vivo gene therapy using liposomes is the low transfection efficiency. Comparing transfection efficiency in KB xenograft tumors in mice between NP-F and Tfx20, the luciferase activity by NP-F was about 100-fold higher than that by Tfx20 (data not shown), suggesting that the NP-F nanoplex remained small enough to migrate into the tumorous tissue. Plasma folic acid may interfere with the binding of FR. The human serum folic acid concentration, following the recent FDA-mandated dietary supplementation, is B42 nM. 31 Earlier reports indicated that serum folic acid at this concentration should not significantly inhibit the binding of FR mediated by liposomes. 22 Results of the present study showed that the mice were actually able to maintain a plasma folate level within the physiologic range of humans on a folate-deficient diet. In contrast, the mice on a normal diet maintained a much higher serum concentration of folic acid. The results of this study, therefore, should be considered relevant to humans with respect to serum folate levels.
In gene therapy in vivo, we demonstrated that the NP-F nanoplex of pCMV-tk followed by GCV treatment could significantly suppress the growth of KB tumor xenografts (Fig 7a-c) . The combination of pCMV-tk and pSV40-Cx43 suppressed LNCaP tumor growth in vivo compared with the control (Fig 8) . The observed reduction in tumor size may not be wholly due to the direct effect of the phosphorylated GCV on the transduced tumor cells. An indirect mechanism (the bystander effect) might be contributing to the antitumor activity. It is reported that a 1-5% in vivo transfection efficiency could generate a significant antitumor effect in suicide gene therapy. 32 In our study, we observed the strong expression of GFP by NP-F in 2-3% of prostate cancer cells, and a weak expression in almost all other cells (Fig 5a) . Moreover, we demonstrated that the NP-F nanoplex showed strong luciferase activity in KB tumor xenografts (data not shown). Therefore, we believe that the transfection efficiency of NP-F is sufficient to inhibit cell growth in vivo.
In this study, we showed that folate-linked nanoparticles could effectively deliver genes in human prostate cancer and nasopharyngeal cancer cells, resulting in an increase in sensitivity of both cells to GCV. In suicide gene therapy, transfection of pCMV-tk by NP-F and GCV treatment could suppress the growth of LNCaP and KB tumor xenografts. Furthermore, we detected the expression of FR protein immunohistochemically in human prostate cancer biopsy specimens. These findings indicate that folate-linked nanoparticles have potential as a clinically effective vector in prostate and nasopharyngeal cancer suicide gene therapy.
